MX9306467A - NOVEL FORMULATION. - Google Patents

NOVEL FORMULATION.

Info

Publication number
MX9306467A
MX9306467A MX9306467A MX9306467A MX9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A
Authority
MX
Mexico
Prior art keywords
novel formulation
vacuum atmosphere
solution
atmosphere
polyoxypropylene
Prior art date
Application number
MX9306467A
Other languages
Spanish (es)
Inventor
Mary Sou
Craig William Davis
Alison Green Floyd
Original Assignee
Wellcome Foudation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foudation Limited filed Critical Wellcome Foudation Limited
Publication of MX9306467A publication Critical patent/MX9306467A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Packages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un contenedor sellado farmacéuticamente aceptable el cual contiene en una atmósfera al vacío o en una atmósfera al vacío o en una atmósfera inerte una solución inyectable acuosa estéril de un copolímero de bloque de polioxipropileo/polioxietileno, estando la solución substancialmente libre de un antioxidante y estando regulada a un pH de 5.5. a 6.5.A pharmaceutically acceptable sealed container which contains in a vacuum atmosphere or in a vacuum atmosphere or in an inert atmosphere a sterile aqueous injectable solution of a polyoxypropylene / polyoxyethylene block copolymer, the solution being substantially free of an antioxidant and being regulated at a pH of 5.5. to 6.5.

MX9306467A 1992-10-19 1993-10-18 NOVEL FORMULATION. MX9306467A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation

Publications (1)

Publication Number Publication Date
MX9306467A true MX9306467A (en) 1994-05-31

Family

ID=10723654

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306467A MX9306467A (en) 1992-10-19 1993-10-18 NOVEL FORMULATION.

Country Status (19)

Country Link
EP (1) EP0671919A1 (en)
JP (1) JPH08502284A (en)
KR (1) KR950703345A (en)
AU (1) AU674895B2 (en)
BR (1) BR9307268A (en)
CA (1) CA2147889A1 (en)
CZ (1) CZ63395A3 (en)
GB (1) GB9221883D0 (en)
HU (1) HUT75701A (en)
IL (1) IL107313A0 (en)
MX (1) MX9306467A (en)
NO (1) NO951462L (en)
NZ (1) NZ256890A (en)
PL (1) PL308459A1 (en)
SI (1) SI9300545A (en)
SK (1) SK44795A3 (en)
TW (1) TW276183B (en)
WO (1) WO1994008596A1 (en)
ZA (1) ZA937714B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2185162A4 (en) * 2007-08-10 2012-04-25 Synthrx Inc Polymer therapy for the treatment of chronic microvascular diseases
CA2927361A1 (en) 2013-10-16 2015-04-23 Mast Therapeutics, Inc. Diuretic induced alterations of plasma volume
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
EP3747448A1 (en) 2014-07-07 2020-12-09 LifeRaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
CN109432511A (en) * 2018-12-29 2019-03-08 常州乐奥医疗科技股份有限公司 A kind of temperature-sensitive hydrogel and its preparation method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
DE3234084A1 (en) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen PHARMACEUTICAL PREPARATIONS FOR TREATING UNWANTED GROWTHS AND THEIR USE
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia

Also Published As

Publication number Publication date
IL107313A0 (en) 1994-01-25
TW276183B (en) 1996-05-21
SK44795A3 (en) 1996-05-08
KR950703345A (en) 1995-09-20
CA2147889A1 (en) 1994-04-28
CZ63395A3 (en) 1995-07-12
HUT75701A (en) 1997-05-28
NZ256890A (en) 1995-10-26
WO1994008596A1 (en) 1994-04-28
EP0671919A1 (en) 1995-09-20
PL308459A1 (en) 1995-07-24
NO951462L (en) 1995-06-13
HU9501104D0 (en) 1995-06-28
ZA937714B (en) 1995-04-18
GB9221883D0 (en) 1992-12-02
AU5284293A (en) 1994-05-09
JPH08502284A (en) 1996-03-12
NO951462D0 (en) 1995-04-18
BR9307268A (en) 1999-05-11
SI9300545A (en) 1994-06-30
AU674895B2 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
AU554402B2 (en) Double sterile package
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
IT1232243B (en) Cyclosporin compsns. in microemulsion or pre-concentrate form
DE59310197D1 (en) STORAGE STABLE AQUEOUS PHARMACEUTICAL PREPARATIONS BY G-CSF
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
MX9710206A (en) Pharmaceutical amiodarone composition for parenteral delivery.
AU3855297A (en) Pharmaceutical composition for treating papillomavirus tumours and infection
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
AU625083B2 (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)- en-20-yn-3-one
KR910021375A (en) Crystalline salt of 4- (di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz [cd] indole
MX9306467A (en) NOVEL FORMULATION.
AU4445089A (en) Lactamimides in the treatment of drug-resistant protozoal infections
AU4434189A (en) An anti-human immunodeficiency virus composition
IT1243193B (en) ORAL PHARMACEUTICAL COMPOSITIONS BASED ON MELATONIN
DK0517160T3 (en) Ophthalmic extended release preparations
DE59409275D1 (en) Tablets with certain grain size thioctic acid
AU674379B2 (en) Antitussive
IT1260469B (en) BOXING MACHINE FOR VIALS IN PARTICULAR OF THE GLASS TYPE FOR MEDICAL USE
SG49770A1 (en) Pharmaceutical preparation
NZ333656A (en) Liquid formulation comprising less 5% w/w saturated polyglycosylated C8-10 glycerides (capryl caproyl macrogol glycerides) and a non-peptide for oro-mucosal administration
YU65493A (en) NEW BLOCK COPOLYMER PREPARATION
NZ236888A (en) Antibiotic deoxymulundocandin, preparation from aspergillus sydowii culture
ATE126064T1 (en) MEDICINAL COMPOSITIONS FOR RECTAL ADMINISTRATION CONTAINING FREEZE-DRIED CALCITONIN.
AU3279889A (en) 1-dimethylcarbamoyl-3-substituted-5-substituted-1h-1,2,4- triazoles